Coronavirus Disease 2019 (COVID-19) vaccine by China National Biotec Group for Coronavirus Disease 2019 (COVID-19) Pneumonia: Likelihood of Approval

Coronavirus Disease 2019 (COVID-19) vaccine is under clinical development by China National Biotec Group and currently in Phase III for Coronavirus Disease 2019 (COVID-19) Pneumonia.

Biotech mega-rounds, a cancer vaccine setback & CEOs keep their promise

Why is it surprising when drug executives stay true to their word? And can neoantigen cancer vaccines work? We cover all that and more this

April 4, 2024

Paul Offit Debunks Florida Surgeon General’s Anti-Vax Warning

Florida Surgeon General Joseph Ladapo, MD, PhD, recently issued a statement that COVID-19 mRNA vaccines should not be used. In this video interview, Paul Offit,

January 6, 2024

TerSera’s ZOLADEX LA receives Health Canada approval

The new dosing option of ZOLADEX is aimed at pre and perimenopausal women with an increased recurrence or advanced breast cancer risk. Credit: Gorodenkoff /

May 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.